The anti-corruption storm affected domestic pharmaceutical enterprises, and Guangyao subsidiaries were involved

Great wisdom astak news agency, Aug 5, 2008: baiteqiao, a subsidiary of Guangyao group, was exposed to bribe Chinese officials through fictitious meetings and other means, becoming the first domestic enterprise involved in the anti-corruption storm since the outbreak of the bribery scandal of foreign pharmaceutical enterprises in China Baxter, the world's largest supplier of parenteral nutrition drugs, said employees of Guangzhou Baxter Qiaoguang medical supplies Co., Ltd., which was set up by the company in cooperation with Guangzhou Pharmaceutical Group, illegally handled marketing expenses through fictitious meetings and other means, and used to bribe professionals in the Chinese medical sector, so as to enable ClinOleic, Baxter's infusion emulsion, to enter the Chinese medical insurance catalog Baite Qiaoguang is a joint venture company established by Baiyunshan Guangyao and Baite in August 2007, with a total investment of more than 500 million yuan, each accounting for 50% of the equity, and a 30-year cooperation period However, according to Baiyunshan A's annual report, Baite Qiaoguang has lost money for four consecutive years since its establishment Until 2011, Baite Qiaoguang turned loss into profit and realized a net profit of 4.75 million yuan In 2012, Baite Qiaoguang realized an annual operating revenue of 311 million yuan and a net profit of 7.2903 million yuan Compared with the global sales of US $14.2 billion of Baite international last year, Baite Qiaoguang's contribution to Baite's performance is not significant Baite said that in July last year, the company received a report from the internal employees of Baite Qiaoguang, so the joint venture was investigated, and the leadership of the joint venture was disciplined, and new training was carried out The reason why the internal investigation was not disclosed before is that the importance of Baxter Qiaoguang's contribution to Baxter's performance is general Guangyao group later issued a statement to clear the relationship, saying that the daily operation of Baite Qiaoguang is dominated by Baite side, and the business management mode is also built according to the structure of Baite company The company is deeply sorry to learn that there is a violation of rules and regulations by the company, and has severely condemned this behavior It is hoped that the management of the company can operate in strict accordance with Chinese laws and regulations On July 15, the bribery of GSK executives in China was exposed, and various ministries and commissions intervened in the investigation one after another Several foreign pharmaceutical enterprises, such as Sanofi and Lilly, were investigated by the industrial and commercial departments, and the anti-corruption storm in the industry was coming Some people believe that gold sales is a common problem in the pharmaceutical industry The state's crackdown on commercial bribery may affect the prosperity of the whole industry Before 2006, the state had launched a large-scale anti commercial bribery action in the pharmaceutical industry, which shocked the industry greatly There were 1310 loss making enterprises in the pharmaceutical industry in that year, with a total loss of 4.402 billion yuan, and the profit growth rate of the whole industry was 10.61%, significantly lower than the level of previous years.